Atlas Trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Monoclonal Gammopathy of Undetermined Significance (MGUS)

RecordFirmDate
Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging (NCT07624760)University of Zurich2026-10-01
Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution (NCT07214324)Azienda USL Reggio Emilia - IRCCS2025-03-17
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study (NCT06644625)Wake Forest University Health Sciences2025-03-01
A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells (NCT07057583)Mayo Clinic2025-02-01
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy (NCT06690593)Zhujiang Hospital2024-12-26
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma (NCT06140524)Regeneron Pharmaceuticals2024-09-16
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH (NCT05283993)Peking University First Hospital2021-07-01
The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss (NCT03951220)Oxford University Hospitals NHS Trust2018-03-29
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome (NCT02269592)Dana-Farber Cancer Institute2014-08-01

Track Monoclonal Gammopathy of Undetermined Significance (MGUS) automatically

Every clearance here is in the API, with alerts when new ones post.